hotspot -WSS

hotspot

author：focus 2025-09-03 03:21:35 - browse：9179

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： American woman, child freed after being kidnapped in Haiti last month

WSS

To bolster infectious disease surveillance, genomics powerhouses team up

Inaction leaves children at risk from dangerous chemotherapy drug

CVS is on a mission to consolidate health care. Will it work?

FDA sets aggressive timeline for overhauling inspection procedures

Drastic changes should bring profitability, startup health insurers say

FDA endorses new sterilization method for medical devices

hotspot

hotspot

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Police still searching for prisoner who escaped from NYC hospital

Malaria cases in Florida and Texas: Here’s what you need to know

Naloxone nonprofit donates 200,000 doses after FDA approval

Dobbs anniversary: the lost opportunity of abortion as health care

Dana Farber says 6 studies to be retracted and 31 corrected

Tori Bowie and the unacceptable rates of Black maternal death

The best solution to the drug shortages problem

Supreme Court strikes down use of affirmative action

Medicare bonuses could stop drug shortages under Senate plan

knowledge

Man killed during FBI raid in connection with threats against Biden, other officials

Inaction leaves children at risk from dangerous chemotherapy drug

Anavex keeps shifting the goalposts in its clinical trials

Immunocompromised patients offer clues on chronic Covid

HPV vaccine, cervical cancer study delivers historic results

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

leisure time

knowledge

explore

explore